Table 1 Tumour and treatment characteristics according to the histological type of the invasive breast carcinoma
Ductal ( N =672) | Lobular ( N =78) | ||||
---|---|---|---|---|---|
Total | N | % | N | % | P |
Age (DM=0) | <10−2 | ||||
 Median (min–max) in years | 46 (24–70) | 49 (39–68) | |||
Menopause (DM=0) | 0.88 | ||||
 Yes | 167 | 25 | 20 | 26 | |
 No | 505 | 75 | 58 | 74 | |
Clinical T stage (DM=0) | 0.03 | ||||
 T2 | 506 | 75 | 50 | 64 | |
 T3 | 166 | 25 | 28 | 36 | |
Clinical N stage (DM=0) | 0.16 | ||||
 N0 | 411 | 61 | 54 | 69 | |
 N1 | 261 | 39 | 24 | 31 | |
Tumour clinical maximal diameter (DM=0) | <10−3 | ||||
 Median (min–max) in mm | 40 (20–70) | 50 (25–70) | |||
Histological grade (DM=4)a | <10−3 | ||||
 1 | 82 | 12 | 32 | 41 | |
 2 | 332 | 50 | 30 | 38 | |
 3 | 210 | 31 | 7 | 9 | |
Mitoses per 10 HPF (DM=72) | <10−3 | ||||
 (0–10) | 129 | 21 | 53 | 80 | |
 (11–21) | 182 | 30 | 7 | 11 | |
 ⩾22 | 291 | 48 | 6 | 9 | |
Hormonal receptors (DM=118) | 0.02 | ||||
 ER+ and/or PR+ | 412 | 73 | 54 | 87 | |
 ER−/PR− | 158 | 28 | 8 | 13 |